CXCR1 and head and neck squamous cell carcinoma: Therefore, we utilized the syngeneic MOC1 murine model of HPV-negative HNSCC both subcutaneously and orthotopically to elucidate how CXCR1/2 inhibition plus docetaxel reshapes the tumor immune microenvironment.